Evidence map›Paper›PMID 26798659›Full record

ReviewJournal of immunology research2015

Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.

Haoshu Fang, Wei Jiang, Jin Cheng, Yan Lu, Anding Liu, Lixin Kan, Uta Dahmen

Open access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Dysregulation of neutrophil in sepsis: recent insights and advances.Cell communication and signaling : CCS · 2025
    Review
  3. Review
  4. Review
  5. IL-33-mediated Eosinophilia Protects against Acute Lung Injury.American journal of respiratory cell and molecular biology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Haoshu FangDepartment of Pathophysiology, Anhui Medical University, Hefei 230032, China.
Wei JiangDepartment of Pathophysiology, Anhui Medical University, Hefei 230032, China.
Jin ChengDepartment of Pathophysiology, Anhui Medical University, Hefei 230032, China.
Yan LuDepartment of Pathophysiology, Anhui Medical University, Hefei 230032, China.
Anding LiuExperimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Lixin KanDepartment of Pathophysiology, Anhui Medical University, Hefei 230032, China; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Uta DahmenExperimental Transplantation Surgery, Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany.
Anhui Medical University · CNHuazhong University of Science and Technology · CNJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis and SIRS (systemic inflammatory response syndrome) belong to a severe disease complex characterized by infection and/or a whole-body inflammatory state. There is a growing body of evidence that neutrophils are actively involved in sepsis and are responsible for both release of cytokines and phagocytosis of pathogens. The neutrophil level is mainly regulated by G-CSF, a cytokine and drug, which is widely used in the septic patient with neutropenia. This review will briefly summarize the role of neutrophils and the therapeutic effect of G-CSF in sepsis. We further suggest that targeting neutrophil function to modulate the balance between innate immunity and inflammatory injury could be a worthwhile therapeutic strategy for sepsis.

Indexed as

Acute-Phase ProteinsAnimalsCarrier ProteinsDisease Models, AnimalGene Expression RegulationGranulocyte Colony-Stimulating FactorHumansImmunity, InnateLipopolysaccharide-Binding ProteinMembrane GlycoproteinsMiceNeutrophilsNF-kappa BPhagocytosisSepsisSystemic Inflammatory Response SyndromeAcute-Phase ProteinsCarrier ProteinsGranulocyte Colony-Stimulating FactorLipopolysaccharide-Binding ProteinMembrane GlycoproteinsNF-kappa BTLR4 protein, humanToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID26798659
PMCPMC4699010
OpenAlexW2205452147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.